Company Filing History:
Years Active: 2017
Title: Martin M Schumacher: Innovator in Cardiovascular Research
Introduction
Martin M Schumacher is a notable inventor based in Sissach, Switzerland. He has made significant contributions to the field of cardiovascular research, particularly through his innovative patent related to cox-2 inhibitory compounds. His work aims to enhance the understanding and detection of cardiovascular side effects associated with these compounds.
Latest Patents
One of Martin M Schumacher's key patents is titled "Biomarkers for cardiovascular side-effects induced by cox-2 inhibitory compounds." This invention focuses on methods for detecting the presence of minimal or early vasculitis or other vasculopathies in subjects who have been administered cox-2 inhibitors. The patent also covers the selection of cox-2 inhibitory compounds, their use in the manufacture of anti-inflammatory medicaments, and vaccination strategies. Martin holds 1 patent in this area.
Career Highlights
Martin M Schumacher is associated with Firalis Sas, a company that specializes in innovative solutions in the biomedical field. His work at Firalis Sas has allowed him to explore and develop groundbreaking methods that contribute to the understanding of cardiovascular health.
Collaborations
Throughout his career, Martin has collaborated with notable colleagues, including Hueseyin Firat and Julie Boisclair. These collaborations have fostered a productive environment for research and innovation in the field of cardiovascular medicine.
Conclusion
Martin M Schumacher's contributions to cardiovascular research through his innovative patent demonstrate his commitment to advancing medical science. His work continues to impact the understanding of the effects of cox-2 inhibitors, paving the way for future developments in the field.